Estela Castillo
Adult Health · New York, NYNPI 1902405541
Payments from drug & device makers
Across 83 payments — averaging $28.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$458
- Gilead$323
- Novartis$322
- Astellas Pharma US Inc$200
- Merck$139
- Seagen Inc.$125
- plus $802 from 19 others
What the payments were for
- Food & beverage$2,12690%
- Education$24510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 11 | $458 |
| Gilead | 10 | $323 |
| Novartis | 16 | $322 |
| Astellas Pharma US Inc | 8 | $200 |
| Merck | 7 | $139 |
| Seagen Inc. | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 4 | $91 |
| EMD Serono, Inc. | 2 | $68 |
| AstraZeneca | 2 | $68 |
| Immunocore Limited | 3 | $67 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $65 |
| Rigel Pharmaceuticals, Inc. | 2 | $63 |
| Bristol Myers Squibb | 2 | $45 |
| Legend Biotech USA Inc. | 2 | $45 |
| Bayer | 2 | $43 |
| Sobi, Inc | 1 | $31 |
| Stemline Therapeutics Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Tersera Therapeutics LLC | 1 | $26 |
| CTI Biopharma Corp. | 1 | $25 |
| Foundation Medicine, Inc. | 1 | $24 |
| Amgen | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $18 |
| Morphosys, US Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADCETRIS$125
How this compares
$2,371 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atovaquone | 17 | $16,851 |
| Acyclovir | 22 | $259 |
Paid to pharmacies, not to this prescriber.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.